Page last updated: 2024-10-26

doxazosin and MEA 2a

doxazosin has been researched along with MEA 2a in 2 studies

Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Iglesias, P1
Santacruz, E1
García-Sancho, P1
Marengo, AP1
Guerrero-Pérez, F1
Pian, H1
Fajardo, C1
Villabona, C1
Díez, JJ1
Scholten, A1
Vriens, MR1
Cromheecke, GJ1
Borel Rinkes, IH1
Valk, GD1

Other Studies

2 other studies available for doxazosin and MEA 2a

ArticleYear
Pheochromocytoma: A three-decade clinical experience in a multicenter study.
    Revista clinica espanola, 2021, Volume: 221, Issue:1

    Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Age

2021
Hemodynamic instability during resection of pheochromocytoma in MEN versus non-MEN patients.
    European journal of endocrinology, 2011, Volume: 165, Issue:1

    Topics: Adrenal Gland Neoplasms; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-1 Receptor Antagon

2011